Ebeling Thomas 4
4 · Cullinan Therapeutics, Inc. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Ebeling Thomas
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-10$13.00/sh+18,450$239,850→ 186,653 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-10−18,450→ 0 totalExercise: $13.00From: 2024-06-08Exp: 2033-06-07→ Common Stock (18,450 underlying)